Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride worsens heart damage from nandrolone decanoate but protects against cell damage.

Men with early-onset hair loss have more heart disease risk factors.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

New therapies are being developed that target integrin pathways to treat various diseases.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men with male pattern baldness are more likely to have unhealthy blood lipid levels, which could signal other health issues.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Adenosine can help treat hair loss by promoting hair growth.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Quercetin may help with PCOS symptoms, but more research is needed.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.